Review article: distinctions between ileal and colonic Crohn's disease: from physiology to pathology-Reference-Cited by-同舟云学术

Review article: distinctions between ileal and colonic Crohn's disease: from physiology to pathology

Published:2021-07-23 Issue:6 Volume:54 Page:779-791
ISSN:0269-2813
Container-title:Alimentary Pharmacology & Therapeutics
language:en
Short-container-title:Aliment Pharmacol Ther

Author:

Pierre Nicolas¹^ORCID,Salée Catherine¹,Vieujean Sophie¹²,Bequet Emeline¹³,Merli Angela‐Maria¹,Siegmund Britta⁴,Meuwis Marie‑Alice¹²,Louis Edouard¹²

Affiliation:

1. Laboratory of Translational Gastroenterology GIGA‐InstituteUniversity of Liège Liège Belgium

2. Hepato‐Gastroenterology and Digestive Oncology Department Liège University Hospital Liège Belgium

3. Division of Gastroenterology, Hepatology and Nutrition Department of Pediatrics Liège University Hospital Liège Belgium

4. Division of Gastroenterology, Infectiology and Rheumatology Medical Department Charité – Universitätsmedizin BerlinCorporate Member of Freie Universität BerlinHumboldt‐Universität zu Berlin and Berlin Institute of Health Berlin Germany

Funder

Fonds De La Recherche Scientifique - FNRS

Publisher

Wiley

Subject

Pharmacology (medical),Gastroenterology,Hepatology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/apt.16536

Reference131 articles.

1. Inherited determinants of Crohn's disease and ulcerative colitis phenotypes: a genetic association study

2. Loss of Response to Anti-TNFs: Definition, Epidemiology, and Management

3. Personalised medicine in Crohn's disease

4. Location is important: differentiation between ileal and colonic Crohn’s disease

5. Should We Divide Crohn’s Disease Into Ileum-Dominant and Isolated Colonic Diseases?

Cited by 16 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. From serum metabolites to the gut: revealing metabolic clues to susceptibility to subtypes of Crohn’s disease and ulcerative colitis;Frontiers in Endocrinology;2024-08-08

2. Real-world Clinical Effectiveness and Safety of Vedolizumab and Adalimumab in Biologic-naive Patients With Crohn’s Disease;Journal of Clinical Gastroenterology;2024-08-02

3. The utility of capsule endoscopy in the phenotype of Crohn’s disease. Data from England 2016–2021;Arab Journal of Gastroenterology;2024-08

4. Calprotectina fecal elevada: ¿la cápsula endoscópica tiene un impacto en el algoritmo de diagnóstico?;Revista de Gastroenterología de México;2024-08

5. Small bowel Crohn's disease: Proximal lesions linked to increased inflammation and biologic treatment needs;Gastroenterología y Hepatología;2024-08